Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Phylum Basidiomycota01:26

Fungal Phylum Basidiomycota

346
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
346
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

318
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
318
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

176
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
176
Taste Buds and Receptors01:20

Taste Buds and Receptors

3.1K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
3.1K
Overview of Fungi01:29

Overview of Fungi

281
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
281
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

293
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of probiotics in restoring and maintaining vaginal microbiome health: a review.

Infection and immunity·2026
Same author

Bioassay-guided Isolation of Antibacterial Compounds from Ethanolic Extract of Alstonia scholaris (L.) R. Br. Leaves and Developmental Toxicity Evaluation in Zebrafish (Danio rerio) Embryos.

Current microbiology·2026
Same author

Synthesis, Photophysical Characterization, and Anticancer Evaluation of Novel Furochromene Derivatives.

ChemistryOpen·2026
Same author

Microbial interactions of EDTA: recent advances and biological applications in the context of natural product modulation.

Frontiers in antibiotics·2026
Same author

Breaking the Barrier: Cutting-Edge Microbial Strategies Against Candida Biofilm Infections.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same author

Antimicrobial peptides: emerging next-generation strategy for sustainable plant disease management.

Frontiers in antibiotics·2026

Related Experiment Video

Updated: Oct 12, 2025

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

2.1K

Medicinal mushrooms: Clinical perspective and challenges.

Sujogya Kumar Panda1, Walter Luyten2

  • 1Department of Biology, KU Leuven, 3000 Leuven, Belgium; Center of Environment Climate Change and Public Health, RUSA 2.0, Utkal University, Vani Vihar, Bhubaneswar 751004, Odisha, India.

Drug Discovery Today
|November 25, 2021
PubMed
Summary

Medicinal mushrooms show promise for various health benefits, including immune modulation. However, more clinical trials are needed to confirm their therapeutic value due to limited large-scale studies.

More Related Videos

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.7K
Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
06:47

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

Published on: December 5, 2020

6.7K

Related Experiment Videos

Last Updated: Oct 12, 2025

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

2.1K
Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.7K
Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
06:47

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

Published on: December 5, 2020

6.7K

Area of Science:

  • Mycology
  • Pharmacology
  • Clinical Medicine

Background:

  • Mushrooms are globally recognized for nutritional and medicinal properties.
  • Over 130 medicinal effects reported, including anti-diabetic, antioxidant, antimicrobial, anticancer, prebiotic, immunomodulating, anti-inflammatory, and cardiovascular benefits.
  • Existing research includes phase I, II, and III clinical trials for various diseases and immune modulation.

Purpose of the Study:

  • To review existing clinical studies on medicinal mushrooms and their preparations.
  • To evaluate the current evidence for therapeutic applications of medicinal mushrooms.
  • To identify gaps in research, particularly concerning clinical trial scale and rigor.

Main Methods:

  • Systematic review of published clinical studies.
  • Focus on trials involving medicinal mushroom preparations, not isolated compounds.
  • Analysis of trial phases, patient numbers, and reported outcomes.

Main Results:

  • Promising clinical data exists, particularly for immune modulation.
  • Few phase III clinical trials have been conducted.
  • Many existing trials involve a limited number of patients.

Conclusions:

  • Medicinal mushrooms demonstrate potential therapeutic benefits.
  • Further rigorous clinical research, especially large-scale phase III trials, is necessary.
  • Clarifying the definitive therapeutic value of mushrooms requires more extensive investigation.